Nano drug-delivery systems in cancer therapy: gains, pitfalls and considerations in DMPK and PD

Ther Deliv. 2010 Aug;1(2):215-9. doi: 10.4155/tde.10.31.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacokinetics*
  • Biological Availability
  • Chemistry, Pharmaceutical
  • Dosage Forms
  • Drug Carriers*
  • Drug Compounding
  • Humans
  • Models, Biological
  • Nanomedicine*
  • Nanoparticles*
  • Technology, Pharmaceutical / methods*
  • Tissue Distribution
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Dosage Forms
  • Drug Carriers